18fluoro-deoxyglucose positron emission tomography evaluation of benign versus malignant osteochondromas: Preliminary observations

Journal of Computer Assisted Tomography

Volumn 30, Issue 5, 2006, Pages 858-864

  Feldman, Frieda ^a   Vanheertum, Ronald ^a   Saxena, Chitra ^a  

^a Department of Orthopaedic Surgery   (United States)

Author keywords

Cartilage; Exostoses; PET

Indexed keywords

DIAGNOSIS; METABOLISM; PHYSIOLOGICAL MODELS; POSITRONS; RADIOGRAPHY; REPAIR; SURGERY;

COSMESIS; EXOSTOSIS; OSTEOCHONDROMA; PIXEL IMAGES; REGION-OF-INTEREST; REGIONS OF INTEREST; SCANNING DEVICE; SITE TO SITES; STANDARD UPTAKE VALUES; WHOLE-BODY;

POSITRON EMISSION TOMOGRAPHY;

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; ARTICLE; BENIGN TUMOR; CARTILAGE; CLINICAL ARTICLE; CONTROLLED STUDY; EXOSTOSIS; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGING; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; OSTEOCHONDROMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCHOOL CHILD; TECHNIQUE; TUMOR RECURRENCE;

EID: 33748552678     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rct.0000228160.86096.ca     Document Type: Article

References (39)

1. Rosenthal DJ, Schiller AL, Mankin HJ. Chondrosarcoma: correlation of radiological and histological grade. Radiology. 1984;50:21-26.
2. Unni KK. Chondrosarcoma. In: Dahlin bone tumors: general aspects and data on 11,087 cases, 5th. Springfield, Ill: Thomas; 1996:71-108.
3. Kivioja A, Ervast H, Kinnune J, et al. Chondrosarcoma in a family with multiple hereditary exostoses. J Bone Joint Surg (Br). 2000;82:B:261-B:266.
4. Ozaki Y, Hillmann A, Blasiuz S, et al. Multicentric malignant transformation of multiple exostoses. Skeletal Radiol. 1998;27:233-236.
5. Wilms R, Hartwig CH, Bohm P, et al. Malignant transformation of a multiple cartilaginous exostosis. A case report. Int Orthop. 1997;21:132-136.
6. Hudson TM, Springfield DS, Spanier SS, et al. Benign exostoses and exostotic chondrosarcomas: evaluation of cartilage thickness by CT. Radiology. 1984;152:595-599.
7. De Beuckeleer LH, De Schepper AM, Ramon F. Magnetic resonance imaging of cartilaginous tumors: is it useful or necessary? Skeletal Radiol. 1996;25:137-141.
8. Geirnaerdt MJA, Hogendoorn PCW, Bloem JL, et al. Cartilaginous tumors: fast contrast-enhanced MR imaging. Radiology. 2000;214(2):539-546.
9. Varman DGK, Ayala AG, Carrasco CH, et al. Chondrosarcoma: MR imaging with pathologic correlation. Radiographics. 1992;12:687-704.
10. Malghem J, VandeBerg B, Noel H, et al. Benign osteochondromas and exostotic chondrosarcomas: evaluation of cartilage cap thickness by ultrasound. Skeletal Radiology. 1992;21:33-37.
11. Aoki J, Watanabe H, Shinozaki T, et al. FDG PET of primary benign and malignant musculoskeletal tumors: standardized uptake values in 52 lesions. Radiology. 2001;219:774-777.
12. Feldman F, VanHeertum R, Manoj C. 18FDG PET scanning of benign and malignant musculoskeletal lesions. Skeletal Radiol. 2003;32:201-208.
13. Franzius C, Daldrup-Linik HE, Wagner-Bohn A, et al. FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging. Annals of Oncology. 2002;13:157-160.
14. Watanabe H, Shinozaki T, Yanagawa T, et al. Glucose metabolic analysis of musculoskeletal tumours using fluorine-FDG PET as an aid to preoperative planning. J Bone and Joint Surg. 2000;82:B:760-B:767.
15. Som P, Atkins HL, Bandaypadhyay D, et al. A fluorinated glucose analog, 2-fluoro-2-Glucose (F18) nontoxic tracer for rapid tumor detection. J Nuc Med. 1980;21:660-675.
16. Hammacher K, Coenen HH, Stocklin G. Efficient stereoscopic synthesis of no-carrier-added 2-(18F) fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nuc Med. 1986;27:235-238.
17. Milgrim JW. The origin of osteochondromas and enchondromas: a histopathologic study. Clin Orthop. 1983;174:264-284.
18. Pritchard D, Unni K. Chondrosarcoma: international Skeletal Soc. Closed Meeting Syllabus Stockholm, Sweden August 25, 1992.
19. Steiner G. Chief of Pathology, Orthopedic Institute NY, NY. Personal Communication; 2004.
20. Feldman F. Cartilaginous tumors and cartilage-forming tumor-like conditions of the bones and soft tissues. In: Ranniger K, ed. Handbuch der medizinischen radiology. Vol. 6. Berlin Heidelberg New York: Springer-Verlag; 1977:83-108.
21. Murphey MD, Choi J, Kransdorf MJ, et al. Imaging of osteochondroma: variants and complications with radiologic-pathologic correlation. Radiographics. 2000;20:1407-1434.
22. Lee KCY, Davies AM, Cassar-Pullicino VN. Imaging the complications of osteochondromas. Clin Rad. 2002;57:18-28.
23. Porter DE, Emerton ME, Villanueva-Lopez F, et al. Clinical and radiographic analysis of osteochondromas and growth disturbance in hereditary multiple exostoses. J Pediatr Orthop. 2002;20:246-250.
24. Hecht JT, Hogue D, Strong LC, et al. Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome 11 and loss of heterozygosity for EXT-liked markers on chromosomes 11 and 8. Am J Hum Genet. 1994;56:1125-1131.
25. Carroll KL, Yandow SM, Ward J, et al. Clinical correlation to genetic variations of hereditary multiple exostoses. J Pediatr Orthop. 1999;19:785-791.
26. Jaffe HL. Hereditary exostoses. Arch Path. 1943;36:355-357.
27. Agress H Jr, Cooper BZ. Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET. Radiology. 2004;230:417-442.
28. Mankin HJ, Lange TA, Spanier SS. The hazards of biopsy in patients with malignant primary bone and soft tissue tumors. J Bone Joint Surg (Am). 1982;64A:1121-1127.
29. Smith MA, O'Doherty MJ. Positron emission tomography and the orthopaedic surgeon. J Bone Joint Surg (Br). 2000;82:B:324-325.
30. Wirganowicz PZ, Watts HG. Surgical risk for elective excision of benign exostoses. J Pediatr Orthop. 1997;17:455-459.
31. Brenner W, Conrad EU, Eary JF. FDG PET imaging for grading and prediction of outcome in chondrosarcoma patients. Eur J Nuc Med. 2004;31:189-195.
32. Krieg JC, Buckwalter JA, Peterson KK, et al. Extensive growth of osteochondroma in a skeletally mature patient. J Bone Joint Surg (Am). 1995;77:A:269-A:273.
33. Castriota-Scanderbeg A, Bonetti MG, Cammisa M, et al. Spontaneous regression of exostoses: two case reports. Pediatr Radiol. 1995;24:544-548.
34. Callan JE, Wood VE. Spontaneous resolution of an osteochondroma. J Bone Joint Surg (Am). 1975;57:723.
35. Paling MR. The "disappearing" osteochondroma. Skeletal Rad. 1963;10:40-42.
36. Feldman F, VanHeertum R, et al. 18FDG PET applications for cartilage neoplasms. Skeletal Radiol. 2005;34:367-374.
37. Zasadny KR, Wahl RL. Standardized values in normal tissues at PET with 2-[F18] fluoro-2-deoxy-D-glucose. Radiology. 1993;89:847-850.
38. Guhlmann A, Brechy-Krauss D, Suger G, et al. Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology. 1998;206:749-754.
39. Kubota R, Yamada S, Kubota K, et al. Intratumoral distribution of fluorine 18-Fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissue studied by microautoradiography. J Nucl Med. 1992;33:1972-1980.